참고문헌
- Sessa, R. and Hata, A. (2013) Role of microRNAs in lung development and pulmonary diseases. Pulm. Circ. 3, 315-328. https://doi.org/10.4103/2045-8932.114758
- Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J. F., Chabot, F., Dromer, C., Pison, C., Reynaud-Gaubert, M., Haloun, A., Laurent, M., Hachulla, E., Cottin, V., Degano, B., Jais, X., Montani, D., Souza, R. and Simonneau, G. (2010) Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122, 156-163. https://doi.org/10.1161/CIRCULATIONAHA.109.911818
- Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297. https://doi.org/10.1016/S0092-8674(04)00045-5
- Friedman, R. C., Farh, K. K., Burge, C. B. and Bartel, D. P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105.
- Hu, Z. H. (2009) Insight into microRNA regulation by analyzing the characteristics of their targets in humans. Bmc Genomics 10, 594-610. https://doi.org/10.1186/1471-2164-10-594
- Courboulin, A., Paulin, R., Giguere, N. J., Saksouk, N., Perreault, T., Meloche, J., Paquet, E. R., Biardel, S., Provencher, S., Cote, J., Simard, M. J. and Bonnet, S. (2011) Role for miR-204 in human pulmonary arterial hypertension. J. Exp. Med. 208, 535-548. https://doi.org/10.1084/jem.20101812
- Kim, J., Kang, Y. J., Kojima, Y., Lighthouse, J. K., Hu, X. Y., Aldred, M. A., McLean, D. L., Park, H., Comhair, S. A., Greif, D. M., Erzurum, S. C. and Chun, H. J. (2013) An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat. Med. 19, 74-82.
- Altuvia, Y., Landgraf, P., Lithwick, G., Elefant, N., Pfeffer, S., Aravin, A., Brownstein, M. J., Tuschl, T. and Margalit, H. (2005) Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33, 2697-2706. https://doi.org/10.1093/nar/gki567
- Lee, Y., Kim, M., Han, J. J., Yeom, K. H., Lee, S., Baek, S. H. and Kim, V. N. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060. https://doi.org/10.1038/sj.emboj.7600385
- Borchert, G. M., Lanier, W. and Davidson, B. L. (2006) RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 13, 1097-1101. https://doi.org/10.1038/nsmb1167
- Kim, V. N. (2005) Small RNAs: Classification, biogenesis, and function. Mol. Cells 19, 1-15. https://doi.org/10.1016/j.molcel.2005.05.026
- Kim, Y. and Kim, V. N. (2012) MicroRNA Factory: RISC assembly from precursor MicroRNAs. Mol. Cell 46, 384-386. https://doi.org/10.1016/j.molcel.2012.05.012
- Kiss, T. (2002) Small nucleolar RNAs: An abundant group of noncoding RNAs with diverse cellular functions. Cell 109, 145-148. https://doi.org/10.1016/S0092-8674(02)00718-3
- Caruso, P., MacLean, M. R., Khanin, R., McClure, J., Soon, E., Southgate, M., MacDonald, R. A., Greig, J. A., Robertson, K. E., Masson, R., Denby, L., Dempsie, Y., Long, L., Morrell, N. W. and Baker, A. H. (2010) Dynamic changes in lung MicroRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscl. Throm. Vas. 30, 716-U182. https://doi.org/10.1161/ATVBAHA.109.202028
- Chandra, S. M., Razavi, H., Kim, J., Agrawal, R., Kundu, R. K., Perez, V. D., Zamanian, R. T., Quertermous, T. and Chun, H. J. (2011) Disruption of the Apelin-APJ system worsens hypoxia-induced pulmonary hypertension. Arterioscl. Throm. Vas. 31, 814-U212. https://doi.org/10.1161/ATVBAHA.110.219980
- Kim, J. (2014) Apelin-APJ Signaling: a potential therapeutic target for pulmonary arterial hypertension. Mol. Cells. 37, 196-201. https://doi.org/10.14348/molcells.2014.2308
- Hogan, B. L. (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10, 1580-1594. https://doi.org/10.1101/gad.10.13.1580
- Long, L., Crosby, A., Yang, X., Southwood, M., Upton, P. D., Kim, D. K. and Morrell, N. W. (2009) Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Circulation 119, 566-576. https://doi.org/10.1161/CIRCULATIONAHA.108.821504
- Machado, R. D., Aldred, M. A., James, V., Harrison, R. E., Patel, B., Schwalbe, E. C., Gruenig, E., Janssen, B., Koehler, R., Seeger, W., Eickelberg, O., Olschewski, H., Elliott, C. G., Glissmeyer, E., Carlquist, J., Kim, M., Torbicki, A., Fijalkowska, A., Szewczyk, G., Parma, J., Abramowicz, M. J., Galie, N., Morisaki, H., Kyotani, S., Nakanishi, N., Morisaki, T., Humbert, M., Simonneau, G., Sitbon, O., Soubrier, F., Coulet, F., Morrell, N. W. and Trembath, R. C. (2006) Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum. Mutat. 27, 121-132. https://doi.org/10.1002/humu.20285
- Brock, M., Trenkmann, M., Gay, R. E., Michel, B. A., Gay, S., Fischler, M., Ulrich, S., Speich, R. and Huber, L. C. (2009) Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ. Res. 104, 1184-1191. https://doi.org/10.1161/CIRCRESAHA.109.197491
- Pullamsetti, S. S., Doebele, C., Fischer, A., Savai, R., Kojonazarov, B., Dahal, B. K., Ghofrani, H. A., Weissmann, N., Grimminger, F., Bonauer, A., Seeger, W., Zeiher, A. M., Dimmeler, S. and Schermuly, R. T. (2012) Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. Am. J. Respir. Crit. Care Med. 185, 409-419. https://doi.org/10.1164/rccm.201106-1093OC
- Brock, M., Samillan, V. J., Trenkmann, M., Schwarzwald, C., Ulrich, S., Gay, R. E., Gassmann, M., Ostergaard, L., Gay, S., Speich, R. and Huber, L. C. (2012) AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension. Eur. Heart J. doi:10.1093/eurheartj/ehs060
- Shintani, M., Yagi, H., Nakayama, T., Saji, T. and Matsuoka, R. (2009) A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. J. Med. Genet. 46, 331-337. https://doi.org/10.1136/jmg.2008.062703
- Drake, K. M., Zygmunt, D., Mavrakis, L., Harbor, P., Wang, L., Comhair, S. A., Erzurum, S. C. and Aldred, M. A. (2011) Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8. Am. J. Respir. Crit. Care Med. 184, 1400-1408. https://doi.org/10.1164/rccm.201106-1130OC
- Zaidi, S. H., You, X. M., Ciura, S., Husain, M. and Rabinovitch, M. (2002) Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 105, 516-521. https://doi.org/10.1161/hc0402.102866
- Takahashi, H., Goto, N., Kojima, Y., Tsuda, Y., Morio, Y., Muramatsu, M. and Fukuchi, Y. (2006) Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L450-458. https://doi.org/10.1152/ajplung.00206.2005
- Mizuno, S., Bogaard, H. J., Kraskauskas, D., Alhussaini, A., Gomez-Arroyo, J., Voelkel, N. F. and Ishizaki, T. (2011) p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 300, L753-761. https://doi.org/10.1152/ajplung.00286.2010
- Caruso, P., Dempsie, Y., Stevens, H. C., McDonald, R. A., Long, L., Lu, R., White, K., Mair, K. M., McClure, J. D., Southwood, M., Upton, P., Xin, M., van Rooij, E., Olson, E. N., Morrell, N. W., MacLean, M. R. and Baker, A. H. (2012) A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circl. Res. 111, 290-300. https://doi.org/10.1161/CIRCRESAHA.112.267591
- Li, S. S., Ran, Y. J., Zhang, D. D., Li, S. Z. and Zhu, D. (2014) MicroRNA-190 Regulates Hypoxic Pulmonary Vasoconstriction by Targeting a Voltage-Gated K Channel in Arterial Smooth Muscle Cells. J. Cell. Biochem. 115, 1196-1205. https://doi.org/10.1002/jcb.24771
- Gou, D., Ramchandran, R., Peng, X., Yao, L., Kang, K., Sarkar, J., Wang, Z., Zhou, G. and Raj, J. U. (2012) miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 303, L682-691. https://doi.org/10.1152/ajplung.00344.2011
- Li, S., Ran, Y., Zhang, D., Chen, J., Li, S. and Zhu, D. (2013) MicroRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1. Biochem. J. 452, 281-291. https://doi.org/10.1042/BJ20120680
- Sarkar, J., Gou, D., Turaka, P., Viktorova, E., Ramchandran, R. and Raj, J. U. (2010) MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am. J. Physiol. Lung Cell. Mol. Physiol. 299, L861-871. https://doi.org/10.1152/ajplung.00201.2010
- Yang, S. Z., Banerjee, S., de Freitas, A., Cui, H. C., Xie, N., Abraham, E. and Liu, G. (2012) miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am. J. Physiol-Lung C. 302, L521-L529. https://doi.org/10.1152/ajplung.00316.2011
- Parikh, V. N., Jin, R. C., Rabello, S., Gulbahce, N., White, K., Hale, A., Cottrill, K. A., Shaik, R. S., Waxman, A. B., Zhang, Y. Y., Maron, B. A., Hartner, J. C., Fujiwara, Y., Orkin, S. H., Haley, K. J., Barabasi, A. L., Loscalzo, J. and Chan, S. Y. (2012) MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension results of a network bioinformatics approach. Circulation 125, 1520-U1216. https://doi.org/10.1161/CIRCULATIONAHA.111.060269
- Guo, L., Qiu, Z. P., Wei, L. P., Yu, X. F., Gao, X., Jiang, S. L., Tian, H., Jiang, C. and Zhu, D. L. (2012) The MicroRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-Type calcium channel-alpha 1C. Hypertension 59, 1006-1013. https://doi.org/10.1161/HYPERTENSIONAHA.111.185413
- Chen, X. Y., Yan, Q., Li, S. D., Zhou, L., Yang, H. J., Yang, Y. X., Liu, X. L. and Wan, X. P. (2012) Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ER alpha-positive endometrioid adenocarcinoma. Cancer Lett. 314, 41-53. https://doi.org/10.1016/j.canlet.2011.09.014
- Kondo, N., Toyama, T., Sugiura, H., Fujii, Y. and Yamashita, H. (2008) miR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res. 68, 5004-5008. https://doi.org/10.1158/0008-5472.CAN-08-0180
- Jalali, S., Ramanathan, G. K., Parthasarathy, P. T., Aljubran, S., Galam, L., Yunus, A., Garcia, S., Cox, R. R., Lockey, R. F. and Kolliputi, N. (2012) Mir-206 Regulates pulmonary artery smooth muscle cell proliferation and differentiation. Plos One 7, e46808. https://doi.org/10.1371/journal.pone.0046808
- Li, X. D., Zhang, X. X., Leathers, R., Makino, A., Huang, C. Q., Parsa, P., Macias, J., Yuan, J. X. J., Jamieson, S. W. and Thistlethwaite, P. A. (2009) Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat. Med. 15, 1289-U1289. https://doi.org/10.1038/nm.2021
- Kang, K., Peng, X., Zhang, X. Y., Wang, Y. N., Zhang, L. S., Gao, L., Weng, T. T., Zhang, H. H., Ramchandran, R., Raj, J. U., Gou, D. M. and Liu, L. (2013) MicroRNA-124 suppresses the transactivation of nuclear factor of activated t cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells. J. Biol. Chem. 288, 25414-25427. https://doi.org/10.1074/jbc.M113.460287
- Wang, D., Zhang, H., Li, M., Frid, M. G., Flockton, A. R., McKeon, B. A., Yeager, M. E., Fini, M. A., Morrell, N. W., Pullamsetti, S. S., Velegala, S., Seeger, W., McKinsey, T. A., Sucharov, C. C. and Stenmark, K. R. (2014) MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ. Res. 114, 67-78. https://doi.org/10.1161/CIRCRESAHA.114.301633
- Creemers, E. E., Tijsen, A. J. and Pinto, Y. M. (2012) Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res. 110, 483-495. https://doi.org/10.1161/CIRCRESAHA.111.247452
- Hergenreider, E., Heydt, S., Treguer, K., Boettger, T., Horrevoets, A. J., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., Braun, T., Urbich, C., Boon, R. A. and Dimmeler, S. (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 14, 249-256. https://doi.org/10.1038/ncb2441
- Turchinovich, A., Weiz, L., Langheinz, A. and Burwinkel, B. (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233. https://doi.org/10.1093/nar/gkr254
- Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. and Remaley, A. T. (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433. https://doi.org/10.1038/ncb2210
- Rhodes, C. J., Wharton, J., Boon, R. A., Roexe, T., Tsang, H., Wojciak-Stothard, B., Chakrabarti, A., Howard, L. S., Gibbs, J. S., Lawrie, A., Condliffe, R., Elliot, C. A., Kiely, D. G., Huson, L., Ghofrani, H. A., Tiede, H., Schermuly, R., Zeiher, A. M., Dimmeler, S. and Wilkins, M. R. (2013) Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 187, 294-302. https://doi.org/10.1164/rccm.201205-0839OC
- Wei, C., Henderson, H., Spradley, C., Li, L., Kim, I. K., Kumar, S., Hong, N., Arroliga, A. C. and Gupta, S. (2013) Circulating miRNAs as potential marker for pulmonary hypertension. Plos One 8, e64396. https://doi.org/10.1371/journal.pone.0064396
피인용 문헌
- Oxidative and nitrosative signalling in pulmonary arterial hypertension — Implications for development of novel therapies vol.165, 2016, https://doi.org/10.1016/j.pharmthera.2016.05.005
- Modulation of miRNAs in Pulmonary Hypertension vol.2015, 2015, https://doi.org/10.1155/2015/169069
- Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension vol.47, pp.7, 2015, https://doi.org/10.1038/emm.2015.45
- A PPARγ-dependent miR-424/503-CD40 axis regulates inflammation mediated angiogenesis vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-02852-4
- MicroRNA‑650 in a copy number‑variable region regulates the production of interleukin 6 in human osteosarcoma cells 2015, https://doi.org/10.3892/ol.2015.3581
- MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1β vol.147, 2016, https://doi.org/10.1016/j.lfs.2016.01.043
- MicroRNA-150 attenuates hypoxia-induced excessive proliferation and migration of pulmonary arterial smooth muscle cells through reducing HIF-1α expression vol.93, 2017, https://doi.org/10.1016/j.biopha.2017.07.028
- Role of Circulating miRNAs as Biomarkers in Idiopathic Pulmonary Arterial Hypertension: Possible Relevance of miR-23a vol.2015, 2015, https://doi.org/10.1155/2015/792846
- Negative regulation of NOD1 mediated angiogenesis by PPARγ-regulated miR-125a vol.482, pp.1, 2017, https://doi.org/10.1016/j.bbrc.2016.11.032
- Effect of miR-23a on anoxia-induced phenotypic transformation of smooth muscle cells of rat pulmonary arteries and regulatory mechanism vol.13, pp.1, 2016, https://doi.org/10.3892/ol.2016.5440
- Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction vol.9, pp.1664-3224, 2018, https://doi.org/10.3389/fimmu.2018.00294
- Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro pp.1745-7254, 2018, https://doi.org/10.1038/s41401-018-0076-9
- MicroRNAs as critical regulators of the endothelial to mesenchymal transition in vascular biology vol.51, pp.2, 2018, https://doi.org/10.5483/BMBRep.2018.51.2.011